Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
about
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Clinical and economic impact o ...... Country university hospitals.
@en
Clinical and economic impact o ...... Country university hospitals.
@nl
type
label
Clinical and economic impact o ...... Country university hospitals.
@en
Clinical and economic impact o ...... Country university hospitals.
@nl
prefLabel
Clinical and economic impact o ...... Country university hospitals.
@en
Clinical and economic impact o ...... Country university hospitals.
@nl
P2093
P2860
P356
P1476
Clinical and economic impact o ...... Country university hospitals.
@en
P2093
Ainhara Lahuerta-Martínez
Arrate Plazaola
Elena Galve-Calvo
Isabel Alvarez-López
Javier Mar
María Gutierrez-Toribio
Nerea Ancizar-Lizarraga
Oliver Ibarrondo
Purificación Martínez Del Prado
Severina Domínguez-Fernández
P2860
P304
P356
10.2147/CEOR.S146095
P407
P577
2018-03-19T00:00:00Z